SCHEMBL24072309

SCHEMBL24072309

O=Nc1cnc(NC(=O)c2ccccc2Nc2ccccc2)s1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.49
▸ KMT2A Q03164 3/20 0.49
▸ RXFP1 Q9HBX9 2/20 0.44
▸ FABP4 P15090 1/20 0.43
▸ MAPK13 O15264 3/20 0.42
▸ MAPK12 P53778 3/20 0.42
▸ MAPK11 Q15759 3/20 0.42
▸ MAPK14 Q16539 3/20 0.42
▸ MAPT P10636 2/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ SIRT2 Q8IXJ6 2/20 0.41
▸ KDR P35968 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ STAT3 P40763 1/20 0.41
▸ MT-CO2 P00403 2/20 0.41
▸ NPC1 O15118 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24073673 0.85 KDM4E (0.58) MEN1KMT2AMAPK13MAPK12MAPK11
SCHEMBL27134415 0.85 RAB9A (0.44) MEN1KMT2AMAPTKDRALDH1A1
SCHEMBL24072387 0.84 KDM4E (0.44) MEN1KMT2ARXFP1MAPTALDH1A1
SCHEMBL27135218 0.83 CYP1A2 (0.55) MEN1KMT2AMAPTALOX15KDR
SCHEMBL27134412 0.83 CCNE1 (0.44) MEN1KMT2AMAPK14MAPTKDR
SCHEMBL24073682 0.82 ALDH1A1 (0.44) MEN1KMT2AMAPTKDRALDH1A1
SCHEMBL24073675 0.82 KDM4E (0.43) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL24072390 0.82 JAK2 (0.47) MEN1KMT2AMAPTALOX15KDR
SCHEMBL27134411 0.81 STAT3 (0.40) MEN1KMT2AMAPK14MAPTKDR
SCHEMBL27134416 0.81 TSHR (0.51) MEN1KMT2AMAPTALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 — — US disclosed
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 — — US disclosed
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2023-02-23 — — US disclosed
WO-2021239117-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI) , INC. (CN) 2021-12-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 MEN1 3254/4885KMT2A 1342/4885RXFP1 3945/4885
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 MEN1 3254/4885KMT2A 1342/4885RXFP1 3945/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback